These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 4811064)

  • 1. Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin.
    Takagi T; Doolittle RF
    Biochemistry; 1974 Feb; 13(4):750-6. PubMed ID: 4811064
    [No Abstract]   [Full Text] [Related]  

  • 2. The subunit structures of human plasma and platelet factor XIII (fibrin-stabilizing factor).
    Schwartz ML; Pizzo SV; Hill RL; McKee PA
    J Biol Chem; 1971 Sep; 246(18):5851-4. PubMed ID: 5096097
    [No Abstract]   [Full Text] [Related]  

  • 3. A peptide released from plasma fibrin stabilzing factor in the conversion to the active enzyme by thrombin.
    Mikuni Y; Iwanaga S; Konishi K
    Biochem Biophys Res Commun; 1973 Oct; 54(4):1393-403. PubMed ID: 4754717
    [No Abstract]   [Full Text] [Related]  

  • 4. On the activation of bovine plasma factor XIII. Amino acid sequence of the peptide released by thrombin and the terminal residues of the subunit polypeptides.
    Nakamura S; Iwanaga S; Suzuki T
    J Biochem; 1975 Dec; 78(6):1247-66. PubMed ID: 1225922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acid sequence of the peptide released from bovine factor XIII following activation by thrombin.
    Nakamura S; Iwanaga S; Suzuki T; Mikuni Y; Konishi K
    Biochem Biophys Res Commun; 1974 May; 58(1):250-6. PubMed ID: 4831071
    [No Abstract]   [Full Text] [Related]  

  • 6. Probing thrombin's ability to accommodate a V34F substitution within the factor XIII activation peptide segment (28-41).
    Isetti G; Maurer MC
    J Pept Res; 2004 Mar; 63(3):241-52. PubMed ID: 15049836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin hydrolysis of V29F and V34L mutants of factor XIII (28-41) reveals roles of the P(9) and P(4) positions in factor XIII activation.
    Trumbo TA; Maurer MC
    Biochemistry; 2002 Feb; 41(8):2859-68. PubMed ID: 11851434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin.
    Schwartz ML; Pizzo SV; Hill RL; McKee PA
    J Biol Chem; 1973 Feb; 248(4):1395-407. PubMed ID: 4405643
    [No Abstract]   [Full Text] [Related]  

  • 9. Structural evidence that the activation peptide is not released upon thrombin cleavage of factor XIII.
    Yee VC; Pedersen LC; Bishop PD; Stenkamp RE; Teller DC
    Thromb Res; 1995 Jun; 78(5):389-97. PubMed ID: 7660355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining thrombin hydrolysis of the factor XIII activation peptide segment leads to a proposal for explaining the cardioprotective effects observed with the factor XIII V34L mutation.
    Trumbo TA; Maurer MC
    J Biol Chem; 2000 Jul; 275(27):20627-31. PubMed ID: 10801785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Our ancient heritage in blood clotting and some of its consequences.
    Laki K
    Ann N Y Acad Sci; 1972 Dec; 202():297-307. PubMed ID: 4508929
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood coagulation: a cybernetic system.
    Seegers WH
    Ser Haematol; 1973; 6(4):549-78. PubMed ID: 4277382
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombin activity is unaltered by N-terminal truncation of factor XIII activation peptides.
    Isetti G; Maurer MC
    Biochemistry; 2004 Apr; 43(14):4150-9. PubMed ID: 15065858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin-independent activation of platelet factor XIII by endogenous platelet acid protease.
    Lynch GW; Pfueller SL
    Thromb Haemost; 1988 Jun; 59(3):372-7. PubMed ID: 2903573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. V34I and V34A substitutions within the factor XIII activation peptide segment (28-41) affect interactions with the thrombin active site.
    Trumbo TA; Maurer MC
    Thromb Haemost; 2003 Apr; 89(4):647-53. PubMed ID: 12669118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site of synthesis of plasma and platelet factor XIII.
    McDonagh J; Wagner RH
    Ann N Y Acad Sci; 1972 Dec; 202():31-40. PubMed ID: 4629555
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative studies on the fibrin-stabilizing factors from human plasma, platelets and placentas.
    Bohn H
    Ann N Y Acad Sci; 1972 Dec; 202():256-72. PubMed ID: 4629553
    [No Abstract]   [Full Text] [Related]  

  • 18. Activation of platelet fibrin-stabilizing factor by thrombin.
    Hung GW; Sonnichsen WJ; James HL; Ganguly P
    Biochim Biophys Acta; 1974 Dec; 371(2):511-8. PubMed ID: 4215455
    [No Abstract]   [Full Text] [Related]  

  • 19. The binding of divalent metal ions to platelet factor XIII modulates its proteolysis by trypsin and thrombin.
    Mary A; Achyuthan KE; Greenberg CS
    Arch Biochem Biophys; 1988 Feb; 261(1):112-21. PubMed ID: 2893589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activation of plasma Factor XIII by acetylated thrombin].
    Orlova AS; Baskova IP
    Biokhimiia; 1977 Feb; 42(2):297-9. PubMed ID: 856308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.